Assistant Clinical Professor of Neurology, Vanderbilt University
Neurology
Dr. Jan L. Brandes, MD
|
|
Give Review
Brandes practices Neurology. She researched medicine at Vanderbilt University School of Medicine. She over the years received 2 awards: "Regional Top Doctor" and "Top MD". Jan L. Brandes, MD is a published doctor. She published 54 publications, including: 'Inhibition of the oxidative and nonoxidative pentose phosphate pathways by somatostatin: a possible mechanism of antitumor action.' She accepts Medicare payments and is listed with Medicare.gov.
Publications
- Randomized, Controlled Study of Telcagepant in Patients With Migraine and Coronary Artery Disease.
- Needle-free subcutaneous sumatriptan for triptan users requiring a change in Migraine therapy: efficacy and impact on patient-rated functionality, satisfaction, and co...
- Satisfaction With and Confidence in Needle-Free Subcutaneous Sumatriptan in Patients Currently Treated with Triptans.
- Childhood maltreatment and migraine (part I). Prevalence and adult revictimization: a multicenter Headache clinic survey.
- Childhood maltreatment and migraine (part II). Emotional abuse as a risk factor for Headache chronification.
- Childhood maltreatment and Migraine (part III). Association with comorbid pain conditions.
- Needle-free subcutaneous sumatriptan (Sumavel DosePro): bioequivalence and ease of use.
- Allodynia in Migraine: association with comorbid pain conditions.
- Safety and tolerability of short-term preventive frovatriptan: a combined analysis.
- Posttraumatic stress disorder in Migraine.
- In-office Discussions of migraine: results from the American Migraine Communication Study.
- The Migraine cycle: patient burden of Migraine during and between Migraine attacks.
- Headache related to pregnancy: management of migraine and migraine Headache in pregnancy.
- Open-label, long-term tolerability of naratriptan for short-term prevention of Menstrually related migraine.
- Depression and anxiety: effect on the Migraine-obesity relationship.
- Sumatriptan-naproxen for acute treatment of Migraine: a randomized trial.
- Assessing the ability of topiramate to improve the daily activities of patients with Migraine.
- The influence of estrogen on Migraine: a systematic review.
- C-reactive protein may be increased in Migraine patients who present with complex clinical features.
- Practical use of topiramate for Migraine prevention.
- Two replicate randomized, double-blind, placebo-controlled trials of the time to onset of pain relief in the acute treatment of Migraine with a fast-disintegrating/rap...
- Treatment approaches to maximizing therapeutic response in Migraine.
- Efficacy and safety of topiramate for the treatment of chronic Migraine: a randomized, double-blind, placebo-controlled trial.
- Migraine and functional impairment.
- Short-term frovatriptan for the prevention of difficult-to-treat Menstrual migraine attacks.
- High prevalence of somatic symptoms and depression in women with disabling chronic Headache.
- Mismatch in how oestrogen modulates molecular and neuronal function may explain Menstrual migraine.
- Eletriptan in the early treatment of acute Migraine: influence of pain intensity and time of dosing.
- History of childhood maltreatment is associated with comorbid depression in women with Migraine.
- Local resection of Tumors of the ampulla of Vater.
- Dehydroepiandrosterone-sulfate inhibits pancreatic carcinoma cell proliferation in vitro and in vivo.
- Oxythiamine and dehydroepiandrosterone inhibit the nonoxidative synthesis of ribose and tumor cell proliferation.
- Nonoxidative pentose phosphate pathways and their direct role in ribose synthesis in tumors: is cancer a Disease of cellular glucose metabolism?
- Thiamine supplementation to cancer patients: a double edged sword.
- Medical treatment of Headache after suboccipital acoustic tumor removal.
- Inhibition of the oxidative and nonoxidative pentose phosphate pathways by somatostatin: a possible mechanism of antitumor action.
- Oxythiamine and dehydroepiandrosterone induce a G1 phase cycle arrest in Ehrlich''s tumor cells through inhibition of the pentose cycle.
- Comparison of postoperative Headache after retrosigmoid approach: vestibular nerve section versus vestibular schwannoma resection.
- Potential of the Migraine Disability Assessment (MIDAS) Questionnaire as a public health initiative and in clinical practice.
- Preference comparison of rizatriptan ODT 10-mg and sumatriptan 50-mg tablet in Migraine.
- Randomized, placebo-controlled trial of rofecoxib in the acute treatment of Migraine.
- Migraine treatment strategies: the global Migraine And Zolmitriptan Evaluation (MAZE) survey--phase IV.
- Impact of Migraine on patients and their families: the Migraine And Zolmitriptan Evaluation (MAZE) survey--Phase III.
- Migraine prevalence and treatment patterns: the global Migraine and Zolmitriptan Evaluation survey.
- Speed of onset, efficacy and tolerability of zolmitriptan nasal spray in the acute treatment of Migraine: a randomised, double-blind, placebo-controlled study.
- Topiramate treatment of chronic Migraine: a randomized, placebo-controlled trial of quality of life and other efficacy measures.
- Randomized controlled study of telcagepant plus Ibuprofen or acetaminophen in Migraine.
- Sex Differences in the Study of Neurological Illnesses.
- Global trends in Migraine care: results from the MAZE survey.
- Topiramate for Migraine prevention: a randomized controlled trial.
- Montelukast for Migraine prophylaxis: a randomized, double-blind, placebo-controlled study.
- Botulinum toxin type a prophylactic treatment of episodic Migraine: a randomized, double-blind, placebo-controlled exploratory study.
- Strategies for optimizing management of Menstrual migraine.
Schools
Vanderbilt Univ Sch Of Med
Vanderbilt University Hospital
Procedures Preformed
- EEG (Electroencephalogram)
- Nerve Block, Somatic
- Non-Cosmetic Chemodenervation
Conditions Treated
- Ataxia
- Cerebral Artery Thrombosis
- Cerebral Palsy
- Cerebrovascular Disease
- View All
Doctors Specialties
- Neurology
Accepted Insurances
Awards
- Regional Top Doctor
- Top MD
Education
-
Vanderbilt University -
Vanderbilt University School of Medicine
Drug Facts
| NPI NUMBER | 1093707937 | |
| NPPES Provider LastName | BRANDES | |
| NPPES Provider FirstName | JAN | |
| NPPES Provider ZIPCode | 372032131 | |
| NPPES Provider State | TN | |
| Specialty Description | Neurology | |
| Total Claim Count | 1860.0 | |
| Distinct Opioid Count | 1.0 | |
| Opioid Claim Count | 40.0 | |
| Percent Opioid Claims | 2.15 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1093707937 |
| Last Name Of The Provider | BRANDES |
| First Name Of The Provider | JAN |
| View All |
Similar Doctors
|
|
Dr. Deidre E. Lanier, MD |
|
|
Dr. Khanh L. Nguyen, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Kita L. Williams, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. James M. Andry Jr., MD |